Plain-English translation of NCT06440915 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is studying how works in children's bodies when used to treat serious fungal infections like aspergillosis or mucormycosis. Researchers will measure the medication's levels in children's blood at different times to understand how each child's body handles it. This information will help doctors personalize treatment and find the safest, most effective doses for each child.
Serious fungal infections can be life-threatening in children, but we don't yet have clear guidelines for the best doses of this medication in young patients. By studying how children's bodies process this treatment, doctors can learn to adjust doses individually, improving both how well the medication works and how safe it is.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive as prescribed by your medical team to treat your fungal infection. At certain times, your doctors will take blood samples to measure how much medication is in your bloodstream and how your body is processing it. The study team will track how well the medication is working and watch for any side effects, using this information to help personalize your treatment plan.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
China